Arvinas (ARVN) Net Margin (2017 - 2026)

Arvinas (ARVN) recorded quarterly Net Margin of 369.23% in Q1 2026, up 47.96% quarter-over-quarter from 709.47% in Q4 2025, and down 41314.0% on a YoY basis from N/an in Q1 2025.

Arvinas (ARVN) Net Margin (2017 - 2026) Analysis & Trends

Arvinas' Net Margin history runs 10 years deep, the most recent figure standing at 369.23% for Q1 2026.

  • In Q1 2026, Net Margin fell 41314.0% year-over-year to 369.23%; the TTM figure through Mar 2026 stood at 247.54% (down 23662.0% YoY), while the FY2025 annual figure was 30.77%, up 4474.0% from the prior year.
  • Net Margin was 369.23% for Q1 2026 at Arvinas, up from 709.47% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 359.16% in Q4 2023 to a low of 709.47% in Q4 2025.
  • Historically, Net Margin has averaged 168.42% across 5 years, with a median of 190.66% in 2022.
  • The sharpest annual moves came in 2022 and 2025: Net Margin jumped 71484 bps in 2022, then tumbled 63329 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 211.9% in 2022, then jumped by 269 bps to 359.16% in 2023, then plunged by 121 bps to 76.18% in 2024, then slumped by 831 bps to 709.47% in 2025, then surged by 48 bps to 369.23% in 2026.
  • The last three Net Margin figures came in at 369.23% (Q1 2026), 709.47% (Q4 2025), and 83.77% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -369.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 -369.23%
Dec 31, 2025 -709.47%
Sep 30, 2025 -83.77%
Jun 30, 2025 -273.21%
Mar 31, 2025 43.91%
Dec 31, 2024 -76.18%
Sep 30, 2024 -48.05%
Jun 30, 2024 -46.01%
Mar 31, 2024 -274.31%
Dec 31, 2023 359.16%
Sep 30, 2023 -184.68%
Jun 30, 2023 -119.82%
Mar 31, 2023 -248.62%
Dec 31, 2022 -211.90%
Sep 30, 2022 -190.66%
Jun 30, 2022 -199.70%
Mar 31, 2022 -230.57%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%
Jun 30, 2021 -914.55%